These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 23482767)
1. Interplay between mast cells and lymphatic vessels in different molecular types of breast cancer. Raica M; Cimpean AM; Ceausu R; Ribatti D; Gaje P Anticancer Res; 2013 Mar; 33(3):957-63. PubMed ID: 23482767 [TBL] [Abstract][Full Text] [Related]
2. Relationship of mast cell density with lymphangiogenesis and prognostic parameters in breast carcinoma. Keser SH; Kandemir NO; Ece D; Gecmen GG; Gul AE; Barisik NO; Sensu S; Buyukuysal C; Barut F Kaohsiung J Med Sci; 2017 Apr; 33(4):171-180. PubMed ID: 28359404 [TBL] [Abstract][Full Text] [Related]
3. [Clinical significance of detection on lymphatic microvessel, lymphatic microvessel density and vascular endothelial growth factor-C in patients with colorectal carcinoma]. Fan YZ; Li GM; Huang GP; Li XP Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Nov; 9(6):477-82. PubMed ID: 17143789 [TBL] [Abstract][Full Text] [Related]
4. [Relation of lymphatic microvessel density detected by monoclonal antibody D2-40 with VEGF-C expression in breast cancer]. Xie XD; Qu SX; Zheng ZD; Song FL; Liu DW Zhonghua Zhong Liu Za Zhi; 2008 May; 30(5):356-60. PubMed ID: 18953835 [TBL] [Abstract][Full Text] [Related]
5. The effect of vascular endothelial growth factor C expression in tumor-associated macrophages on lymphangiogenesis and lymphatic metastasis in breast cancer. Ding M; Fu X; Tan H; Wang R; Chen Z; Ding S Mol Med Rep; 2012 Nov; 6(5):1023-9. PubMed ID: 22923155 [TBL] [Abstract][Full Text] [Related]
6. A meta-analysis of the relationship between lymphatic microvessel density and clinicopathological parameters in breast cancer. Chen Y; Yan J; Yuan Z; Yu S; Yang C; Wang Z; Zheng Q Bull Cancer; 2013 Mar; 100(3):1-10. PubMed ID: 23501839 [TBL] [Abstract][Full Text] [Related]
7. VEGF-C expressing tumor-associated macrophages in lymph node positive breast cancer: impact on lymphangiogenesis and survival. Schoppmann SF; Fenzl A; Nagy K; Unger S; Bayer G; Geleff S; Gnant M; Horvat R; Jakesz R; Birner P Surgery; 2006 Jun; 139(6):839-46. PubMed ID: 16782443 [TBL] [Abstract][Full Text] [Related]
8. Hypoxia inducible factor-1alpha correlates with VEGF-C expression and lymphangiogenesis in breast cancer. Schoppmann SF; Fenzl A; Schindl M; Bachleitner-Hofmann T; Nagy K; Gnant M; Horvat R; Jakesz R; Birner P Breast Cancer Res Treat; 2006 Sep; 99(2):135-41. PubMed ID: 16555123 [TBL] [Abstract][Full Text] [Related]
9. Mast cells stimulate lymphangiogenesis in the gingiva of patients with periodontal disease. Raica M; Cimpean AM; Popovici RA; Balica AR; Vladau M; Gaje PN In Vivo; 2015; 29(1):29-34. PubMed ID: 25600526 [TBL] [Abstract][Full Text] [Related]
10. Lymphangiogenesis and lymphovascular invasion diminishes prognosis in esophageal cancer. Schoppmann SF; Jesch B; Zacherl J; Riegler MF; Friedrich J; Birner P Surgery; 2013 Apr; 153(4):526-34. PubMed ID: 23294880 [TBL] [Abstract][Full Text] [Related]
11. Lymphatic microvessel density and lymphovascular invasion assessed by anti-podoplanin immunostaining in human breast cancer. Schoppmann SF; Birner P; Studer P; Breiteneder-Geleff S Anticancer Res; 2001; 21(4A):2351-5. PubMed ID: 11724292 [TBL] [Abstract][Full Text] [Related]
12. Podoplanin expression in advanced-stage gastric carcinoma and prognostic value of lymphatic microvessel density. Raica M; Ribatti D; Mogoanta L; Cimpean AM; Ioanovici S Neoplasma; 2008; 55(5):455-60. PubMed ID: 18665758 [TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of intratumoral and peritumoral lymphatic density and blood vessel density in invasive breast carcinomas. El-Gohary YM; Metwally G; Saad RS; Robinson MJ; Mesko T; Poppiti RJ Am J Clin Pathol; 2008 Apr; 129(4):578-86. PubMed ID: 18343785 [TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical analysis of lymphatic vessel density and mast cells in oral tongue squamous cell carcinoma. Mafra RP; Serpa MS; Lima KC; Silveira ÉJDD; Souza LB; Pinto LP J Craniomaxillofac Surg; 2018 Dec; 46(12):2234-2239. PubMed ID: 30482715 [TBL] [Abstract][Full Text] [Related]
15. High LYVE-1-positive lymphatic vessel numbers are associated with poor outcome in breast cancer. Bono P; Wasenius VM; Heikkilä P; Lundin J; Jackson DG; Joensuu H Clin Cancer Res; 2004 Nov; 10(21):7144-9. PubMed ID: 15534085 [TBL] [Abstract][Full Text] [Related]
16. Aberrant expression of decoy receptor 3 in human breast cancer: relevance to lymphangiogenesis. Wu Q; Zheng Y; Chen D; Li X; Lu C; Zhang Z J Surg Res; 2014 May; 188(2):459-65. PubMed ID: 24612949 [TBL] [Abstract][Full Text] [Related]
17. Tumor lymphangiogenesis in inflammatory breast carcinoma: a histomorphometric study. Van der Auwera I; Van den Eynden GG; Colpaert CG; Van Laere SJ; van Dam P; Van Marck EA; Dirix LY; Vermeulen PB Clin Cancer Res; 2005 Nov; 11(21):7637-42. PubMed ID: 16278382 [TBL] [Abstract][Full Text] [Related]
18. Intratumoral lymphatics and lymphatic vessel invasion detected by D2-40 are essential for lymph node metastasis in bladder transitional cell carcinoma. Ma Y; Hou Y; Liu B; Li X; Yang S; Ma J Anat Rec (Hoboken); 2010 Nov; 293(11):1847-54. PubMed ID: 20730866 [TBL] [Abstract][Full Text] [Related]
19. Evidence for lymphangiogenesis and its prognostic implications in head and neck squamous cell carcinoma. Kyzas PA; Geleff S; Batistatou A; Agnantis NJ; Stefanou D J Pathol; 2005 Jun; 206(2):170-7. PubMed ID: 15846845 [TBL] [Abstract][Full Text] [Related]
20. Absence of lymphangiogenesis in ductal breast cancer at the primary tumor site. van der Schaft DW; Pauwels P; Hulsmans S; Zimmermann M; van de Poll-Franse LV; Griffioen AW Cancer Lett; 2007 Aug; 254(1):128-36. PubMed ID: 17442484 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]